Enzo Biochem Reports Third Quarter Results

Published: Jun 11, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal third quarter ended April 30, 2013. Among the quarter’s highlights:

•Sequential revenues growth, gross margin improvement and reduced operating loss.

•Following storm-delayed inspection, new diagnostic assays now available to drive revenue growth at Clinical Labs.

Help employers find you! Check out all the jobs and post your resume.

Back to news